Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Neurosci Lett ; 471(1): 34-7, 2010 Feb 26.
Artículo en Inglés | MEDLINE | ID: mdl-20074615

RESUMEN

Nicotine modulates dopaminergic activity in the central nervous system by acting on the reuptake system, including the dopamine transporter (DAT), although precisely remains unclear. Here we investigated the effect of nicotine on the transcriptional regulation of the human DAT (hDAT) gene by conducting luciferase reporter assays. Nicotine enhanced the transcription of hDAT gene constructs in transiently transfected SK-N-SH cells. Hexamethonium, a neuronal (ganglionic) nicotinic acetylcholine receptor antagonist, blocked the action of nicotine. Functional analyses placed the nicotine-responsive region -3.5 to -1.0 kb (from the transcription start site) upstream of the core promotor region. Deletion of intron 1, known as a silencer element of the hDAT gene, abolished nicotine's stimulatory effect. Nicotine failed to stimulate DAT promotor activity in non-neuronal CHO or COS-7 cells or in SK-N-AS cells, another neuronal cell line recently reported as a model for investigating DAT gene expression. These results suggest a nicotinic cholinergic mechanism to be involved in the nicotine-induced up-regulation of DAT gene expression.


Asunto(s)
Proteínas de Transporte de Dopamina a través de la Membrana Plasmática/fisiología , Nicotina/farmacología , Agonistas Nicotínicos/farmacología , Región de Flanqueo 5' , Animales , Línea Celular , Chlorocebus aethiops , Cricetinae , Cricetulus , Proteínas de Transporte de Dopamina a través de la Membrana Plasmática/genética , Genes Reporteros , Hexametonio/farmacología , Humanos , Intrones , Luciferasas/biosíntesis , Luciferasas/genética , Antagonistas Nicotínicos/farmacología , Subunidades de Proteína/biosíntesis , Receptores Nicotínicos/biosíntesis , Transcripción Genética
2.
Tech Coloproctol ; 12(3): 217-23, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18679573

RESUMEN

BACKGROUND: This study was undertaken to evaluate the accuracy of endoanal ultrasonography for preoperative assessment of anal fistula, with special reference to the difference between acute and chronic fistula. METHODS: The subjects comprised 401 patients treated for acute or chronic anorectal sepsis of cryptoglandular origin during the period January through December 2005. All patients underwent physical examination and endoanal ultrasonography. Agreement between the physical and endosonographic findings and the definitive surgical findings were evaluated with special reference to classification of the primary tract and horseshoe extension and localization of the internal opening. The difference in accuracy of endosonographic assessment between acute and chronic fistula was also evaluated. RESULTS: The accuracy of endoanal ultrasonography was significantly higher than that of physical examination in detecting the primary tract (88.8% vs. 85.0%, p=0.0287) and horseshoe extension (85.7% vs. 58.7%, p<0.0001) and in localizing the internal opening (85.5% vs. 69.1%, p<0.0001). Furthermore, localization of the internal opening by endosonography was significantly more accurate in chronic fistula than in acute fistula (89.5 % vs. 76.8%, p<0.0001), although the accuracy in detecting the primary tract and horseshoe extension was not significantly different. CONCLUSIONS: Endoanal ultrasonography is reliable and useful for preoperative assessment of anal fistula, particularly for detecting horseshoe extension and localizing the internal opening. Endosonographic assessment provides clearer depiction of the internal opening during periods of quiescence than during the period of abscess formation. For patients with acute anorectal sepsis, initial surgical drainage and subsequent fistula surgery, rather than one-stage fistula surgery, may be advisable to avoid misidentification of the internal opening.


Asunto(s)
Endosonografía , Examen Físico , Fístula Rectal/diagnóstico , Enfermedad Aguda , Adolescente , Adulto , Anciano , Enfermedad Crónica , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Fístula Rectal/diagnóstico por imagen , Adulto Joven
3.
Toxicol Lett ; 170(1): 75-82, 2007 Apr 05.
Artículo en Inglés | MEDLINE | ID: mdl-17382495

RESUMEN

5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) is a synthetic orally active hallucinogenic tryptamine derivative, known also as Foxy or Foxy methoxy. However, few studies have examined its effects in vitro. In the present study, we investigated the actions of 5-MeO-DIPT against monoamine neurotransmitter transporters, including the transporters for dopamine (DAT), norepinephrine (NET), and serotonin (SERT), using COS-7 cells heterologously expressing these transporters and rat brain synaptosomes. 5-MeO-DIPT specifically inhibited the uptake of [3H]serotonin (5-HT) by the SERT-expressing COS-7 cells and rat striatal synaptosomes in a high affinity manner at concentrations similar to those for cocaine. The effect was reversible and competitive. 5-MeO-DIPT failed to stimulate reverse transport of [3H]5-HT through SERT, while it prevented the releasing action of methamphetamine. 5-MeO-DIPT induced cell toxicity at high concentrations in COS-7 cells, and it was not influenced by the expression of SERT. These results demonstrated that 5-MeO-DIPT acts as a competitive SERT inhibitor and has an inability to cause reverse transport, underlying its serotonergic actions.


Asunto(s)
5-Metoxitriptamina/análogos & derivados , Inhibidores Selectivos de la Recaptación de Serotonina/farmacología , Proteínas de Transporte de Serotonina en la Membrana Plasmática/metabolismo , Sinaptosomas/efectos de los fármacos , 5-Metoxitriptamina/farmacología , Animales , Monoaminas Biogénicas/antagonistas & inhibidores , Supervivencia Celular/efectos de los fármacos , Chlorocebus aethiops , Cocaína/farmacología , Masculino , Metanfetamina/farmacología , Ratas , Ratas Sprague-Dawley , Sinaptosomas/metabolismo
4.
Tech Coloproctol ; 10(4): 357-60, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17115307

RESUMEN

We report two cases of perianal endometriosis in which we were greatly assisted by endoanal ultrasonography. Patient 1 was a 43-year-old woman with perianal pain. Endosonography showed a hypoechoic mass in the anterior perianal region without involvement of the anal sphincter. Local excision was performed under spinal anesthesia without damage to the anal sphincter. Patient 2 was a 30-year-old woman with perianal pain coinciding with her menstrual period. Endosonography showed a heterogeneous mass containing cystic anechoic areas in the right anterior perianal region and involving the external anal sphincter. Wide excision, including the episiotomy scar and part of the external anal sphincter, and primary sphincteroplasty were performed under spinal anesthesia. According to our experience, preoperative endosonography is a reliable technique for visualizing perianal endometriosis and for diagnosing anal sphincter involvement. Operative management should be determined on the basis of preoperative and intraoperative ultrasonographic assessment.


Asunto(s)
Enfermedades del Ano/diagnóstico por imagen , Endometriosis/diagnóstico por imagen , Endosonografía , Adulto , Enfermedades del Ano/cirugía , Endometriosis/cirugía , Femenino , Humanos
5.
Methods Find Exp Clin Pharmacol ; 25(8): 601-6, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-14671676

RESUMEN

Metallothionein (MT) is induced in the liver not only by heavy metals, but also by stress such as starvation. However, the meaning of the induced MT during starvation has never been clear. In this study, we investigated the relationship between changes in hepatic MT synthesis and the hepatic damage that occurs during starvation. MT synthesis was assessed by measuring MT contents and the expression of the MT gene in the liver. The hepatic damage was assessed by measuring glutamic pyruvic transaminase (GPT) and glutamic oxaloacetic transaminase (GOT) activities in the serum. MT synthesis in the liver increased over the normal level by starvation, but decreased under the normal level by refeeding after starvation. Both GPT and GOT activities of the refeeding group were higher than those of the control group. However, MT synthesis increased by a subcutaneous injection with CdCl(2) (1 mg Cd /kg) at the same time as refeeding after starvation. At this point, GOT activity decreased until it reached the normal level. MT synthesis decreased by refeeding after starvation, and from the results found in this study, we proposed the hypothesis that the liver damage caused by refeeding after starvation might be due to the decrease in the synthesis of a sufficient amount of MT induced by metals.


Asunto(s)
Hepatopatías/complicaciones , Metalotioneína/biosíntesis , Inanición/inducido químicamente , Alanina Transaminasa/biosíntesis , Alanina Transaminasa/sangre , Animales , Aspartato Aminotransferasas/biosíntesis , Aspartato Aminotransferasas/sangre , Cloruro de Cadmio/administración & dosificación , Cloruro de Cadmio/farmacocinética , Cloruro de Cadmio/toxicidad , Alimentos , Regulación de la Expresión Génica , Inyecciones Subcutáneas , Hígado/química , Hígado/efectos de los fármacos , Hígado/fisiopatología , Hepatopatías/enzimología , Hepatopatías/fisiopatología , Masculino , Metalotioneína/efectos de los fármacos , Metalotioneína/genética , Ratones , Ratones Endogámicos , ARN Mensajero/biosíntesis , ARN Mensajero/genética , España , Inanición/fisiopatología , Factores de Tiempo
8.
Cytokine ; 15(6): 320-7, 2001 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-11594799

RESUMEN

Midazolam, a benzodiazepine, has an hypnotic effect via benzodiazepine receptors and is widely used as an anaesthetic. Recently, it has been suggested that benzodiazepines modulate cytokine responses. The purpose of the present study was to evaluate the effect of midazolam on interleukin-6 (IL-6) response by observing mRNA expression levels in human peripheral blood mononuclear cells (PBMCs) in the absence of lipopolysaccharide (LPS). PBMCs were isolated from healthy volunteers in endotoxin-free 0.9% sodium chloride solution. The cells were incubated for 2 h at 37 degrees C immediately after isolation. IL-6 mRNA expression levels in the cells were quantified using reverse transcription and competitive polymerase chain reaction. It was found that midazolam time-dependently inhibited the IL-6 mRNA expression in PBMCs in the absence of LPS, and significantly inhibited the IL-6 mRNA expression at 1 microg/ml (P<0.05) or 10 microg/ml (P<0.01) in the absence of LPS. However, neither a specific agonist of peripheral-type benzodiazepine receptors, Ro5-4864, nor a specific agonist of central-type benzodiazepine receptors, clonazepam, inhibited IL-6 mRNA expression. These findings indicated a suppression of the IL-6 response in human PBMCs by midazolam in the absence of LPS, and suggests that midazolam has its effect not via benzodiazepine receptors, but by another mechanism.


Asunto(s)
Ansiolíticos/farmacología , Interleucina-6/biosíntesis , Leucocitos Mononucleares/metabolismo , Lipopolisacáridos/farmacología , Midazolam/farmacología , ARN Mensajero/metabolismo , Anticonvulsivantes/farmacología , Benzodiazepinonas/farmacología , Unión Competitiva , Supervivencia Celular , Células Cultivadas , Clonazepam/farmacología , Convulsivantes/farmacología , ADN Complementario/metabolismo , Relación Dosis-Respuesta a Droga , Agonistas de Receptores de GABA-A , Humanos , Interleucina-6/metabolismo , Ligandos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Tiempo
9.
Toxicol Lett ; 123(2-3): 143-50, 2001 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-11641042

RESUMEN

We investigated the induction of metallothionein (MT) by cadmium (Cd) in the bone tissue of rats. To clarify the cell response to Cd in bone, the isoform-specific expression of MT mRNAs (MT-I and MT-II) was examined by reverse transcriptase-polymerase chain reaction (RT-PCR). Both MT-I and MT-II mRNA levels were increased within 3 h by Cd administration. MT (MT-I/MT-II) localization after single Cd injection were also confirmed by immunohistochemical studies. Notably, MT-positive cells were time-dependently increased, and the positive cells were mainly localized in osteocytes. The cell-specific induction of MT may be associated with Cd accumulation and Cd-induced bone injury in vivo. Furthermore, we also found that MT was consecutively expressed in some osteoclasts of control rats. This finding suggested a new role of osteoclasts in bone metabolism.


Asunto(s)
Huesos/efectos de los fármacos , Cadmio/farmacología , Metalotioneína/genética , Animales , Huesos/química , Huesos/metabolismo , Fémur/química , Fémur/efectos de los fármacos , Fémur/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Inmunohistoquímica , Masculino , Metalotioneína/metabolismo , ARN Mensajero/efectos de los fármacos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Tibia/química , Tibia/efectos de los fármacos , Tibia/metabolismo
10.
Pharmacol Res ; 44(2): 81-7, 2001 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11516255

RESUMEN

The purpose of this study was to evaluate the relationship between the in vivo toxicity and plasma concentration of theophylline. Theophylline was administered intravenously in single doses ( 50, 100, 150 and 200 mg kg(-1)once a day) or repeated doses (12.5, 25 and 90 mg kg(-1)/day for 28 days) in rats. Plasma concentrations of theophylline increased dose-dependently in both single and repeated doses, and there were no differences due to effects of 28-times repeated administration. Neither single dose at 50 mg kg(-1)nor repeated dose at 12.5 mg kg(-1)/day injections of theophylline showed toxic signs, in which plasma concentrations of theophylline were less than 110 and 22.5 microg ml(-1), respectively. Theophylline induced myocardial fibrosis in 25 mg kg(-1)/day and more treated groups: in which plasma concentrations of theophylline were more than 50 microg ml(-1). At doses of 100 mg kg(-1)(single) and 90 mg kg(-1)/day (repeated), theophylline caused tachypnea and excitement of movement. Each theophylline concentration in plasma was more than 194 microg ml(-1)in single 100 mg kg(-1)and 162 microg ml(-1)in repeated 90 mg kg(-1)/day injections, respectively. Death was observed at a dose of 200 mg kg(-1), in which the plasma concentration of theophylline was more than 264 microg ml(-1). Moreover, the recovery period from signs of toxic poisoning to normality in the 200 mg kg(-1)treated group was greater than that in the 150 mg kg(-1)and less treated groups. The results indicated that the in vivo toxicity of theophylline is highly dependent on plasma concentrations in rats which received single and also repeated doses of theophylline.


Asunto(s)
Broncodilatadores/toxicidad , Teofilina/toxicidad , Animales , Broncodilatadores/administración & dosificación , Broncodilatadores/sangre , Cromatografía Líquida de Alta Presión , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Ratas , Factores Sexuales , Teofilina/administración & dosificación , Teofilina/sangre
11.
Jpn J Pharmacol ; 86(1): 65-72, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11430474

RESUMEN

We investigated the induction of metallothionein (MT) by cadmium (Cd) in the dental pulp of rat incisors. Time-course studies of MT mRNA expression after single Cd injection were observed by Northern-blot analysis. The isoform-specific expressions of MT mRNAs (MT-I, MT-II and MT-III) were observed using the reverse transcriptase-polymerase chain reaction (RT-PCR) method. Both MT-I and MT-II mRNA levels increased within 3 h, peaked at 3 h and then decreased. These findings demonstrated that MT-I and MT-II mRNA were rapidly induced by Cd in dental pulp. MT-III mRNA was constitutively expressed in rat dental pulp, but the expression level did not change by Cd treatment. The localization of MT protein in Cd-treated rat dental pulp was determined by immunohistochemical staining using anti-MT antibody against MT-I and MT-II. MT protein was localized in the specific cell type of odontoblasts (secretory odontoblasts and resting odontoblasts). In conclusion, it is likely that stained MT in the immunohistochemical study should be MT-I and/or MT-II. Furthermore, MT-I and/or MT-II in Cd-treated rat dental pulp was localized in odontoblasts, in which accumulation of Cd were reported. The cell-specific synthesis of MT may be associated with its metal storage and detoxification role in dental tissues.


Asunto(s)
Cadmio/farmacología , Pulpa Dental/metabolismo , Metalotioneína/metabolismo , Animales , Northern Blotting , Pulpa Dental/efectos de los fármacos , Inmunohistoquímica , Isomerismo , Masculino , Metalotioneína/biosíntesis , ARN Mensajero/biosíntesis , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factores de Tiempo
12.
Pharmacol Res ; 44(1): 53-7, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11428911

RESUMEN

Metallothioneins (MTs) have a low molecular weight and have been considered to be important metal-binding proteins in defense from cadmium (Cd) toxicity in animals. These proteins are known to be induced by the injection of heavy metals such as Cd. Previously, we developed the measurement of the MT mRNA expression by the RT-PCR method. In this study, to clarify the relation between Cd-induced MT-I mRNA expression and female sex hormones in liver, we investigated the influences of the ovariectomy and female sex hormones on hepatic MT-I mRNA expression after Cd injection, and also investigated the effects of aging on hepatic MT-I mRNA expression in mice after Cd injection. We analysed the MT-I mRNA expression by the RT-PCR method. Cd-induced MT-I mRNA expression in ovariectomized mice was more than that in sham-operated mice (9 weeks old). Both 17 beta -estradiol and progesterone reduced the Cd-induced MT-I mRNA expression in ovariectomized mice (9 weeks old). Moreover, the MT-I mRNA expression in male mice was more than that of females (9 weeks old). However, the sex difference in the gene expression was not found in younger (4 weeks old) or older (46 weeks old) mice. These results suggest that the expression of hepatic MT-I mRNA after Cd injection is influenced by female sex hormones.


Asunto(s)
Cloruro de Cadmio/farmacología , Estradiol/farmacología , Expresión Génica/efectos de los fármacos , Hepatocitos/efectos de los fármacos , Metalotioneína/genética , Progesterona/farmacología , Animales , Interacciones Farmacológicas , Femenino , Hormonas Esteroides Gonadales/farmacología , Hepatocitos/fisiología , Masculino , Metalotioneína/metabolismo , Ratones , Ovariectomía , ARN Mensajero/efectos de los fármacos , ARN Mensajero/metabolismo
13.
Life Sci ; 68(12): 1395-403, 2001 Feb 09.
Artículo en Inglés | MEDLINE | ID: mdl-11388691

RESUMEN

A biscoclaurin alkaloid preparation, cepharanthin (Ceph), is reported to have opposing pharmacological effects, enhancement or depression, on several cells and tissues, although detailed mechanisms remain unclear. Previously, we reported that Ceph enhanced lipopolysaccharide (LPS)-induced histidine decarboxylase (HDC) activity in mice spleens by consecutive pre-administration. In this study, we examined the pharmacological effects on HDC activity of a single Ceph pre-administration to test the influence of the administration method. Consequently, HDC activities were decreased by a single administration 15 minutes before LPS challenge in ddY and ICR mice spleens. Moreover, to further examine this suppressing effect, we employed genetically mast cell-deficient WBB6F1 W/Wv (W/Wv) mice to avoid the influence of mast cells. In W/Wv mice, HDC activity was enhanced, but not in the congenic WBB6F1 +/+ mice. These findings suggest that mast cells influence the depressant effect on HDC activity by a Ceph single administration in mast cell sufficient mice.


Asunto(s)
Alcaloides/farmacología , Antiinflamatorios no Esteroideos/farmacología , Histidina Descarboxilasa/biosíntesis , Lipopolisacáridos/farmacología , Bazo/efectos de los fármacos , Animales , Bencilisoquinolinas , Degranulación de la Célula/efectos de los fármacos , Degranulación de la Célula/genética , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Escherichia coli/inmunología , Masculino , Mastocitos/efectos de los fármacos , Mastocitos/patología , Mastocitos/fisiología , Ratones , Ratones Endogámicos ICR/genética , Ratones Noqueados , Piel/efectos de los fármacos , Piel/patología , Bazo/enzimología
14.
Arch Oral Biol ; 46(9): 829-34, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11420055

RESUMEN

Cavity preparation can increase the active synthesis and secretion of non-collagenous proteins by odontoblasts, thus resulting in the deposition of tertiary dentine. In this study, the effect of cavity preparation on osteonectin expression was examined in odontoblasts of the rat tooth pulp. A class V cavity was prepared in rat first molars to stimulate odontoblastic secretory activity, and the animals were killed at various intervals. In the normal pulp, osteonectin immunoreactivity was detected in odontoblasts but not other cells. At 1 day after cavity preparation, immunoreactivity had diminished beneath the cavity. At 3 days, strong immunoreactivity could be detected in odontoblasts beneath the cavity. Numerous round cells underlying the odontoblastic layer also demonstrated immunoreactivity. Thereafter, the intensity of osteonectin immunoreactivity in odontoblasts beneath tertiary dentine decreased gradually, and at 30 and 60 days, it was weaker than in normal pulp. These findings suggest that osteonectin is actively synthesized by odontoblasts underlying a cavity in the initial stage of tertiary dentine formation.


Asunto(s)
Preparación de la Cavidad Dental , Odontoblastos/metabolismo , Osteonectina/biosíntesis , Animales , Densitometría , Pulpa Dental/citología , Pulpa Dental/metabolismo , Dentina Secundaria/metabolismo , Técnica del Anticuerpo Fluorescente Indirecta , Inmunohistoquímica , Masculino , Ratas , Ratas Sprague-Dawley , Estadísticas no Paramétricas
15.
Acta Med Okayama ; 55(1): 1-9, 2001 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-11246971

RESUMEN

The metallothionein (MT) family is a class of low molecular, intracellular, and cysteine-rich proteins with a high affinity for metals. Although the first of these proteins was discovered nearly 40 years ago, their functional significance remains obscure. Four major isoforms (MT-I, MT-II, MT-III, and MT-IV) have been identified in mammals. MT-I and MT-II are ubiquitously expressed in various organs including the brain, while expression of MT-III and MT-IV is restricted in specific organs. MT-III was detected predominantly in the brain, and characterized as a central nervous system-specific isomer. The role of MTs in the central nervous system has become an intense focus of scientific research. An isomer of MTs, MT-III, of particular interest, was originally discovered as a growth inhibitory factor, and has been found to be markedly reduced in the brain of patients with Alzheimer's disease and several other neurodegenerative diseases. MT-III fulfills unique biological roles in homeostasis of the central nervous system and in the etiology of neuropathological disorders.


Asunto(s)
Encéfalo/metabolismo , Proteínas del Tejido Nervioso/fisiología , Enfermedad de Alzheimer/metabolismo , Secuencia de Aminoácidos , Animales , Lesiones Encefálicas/metabolismo , Regulación de la Expresión Génica , Humanos , Metalotioneína 3 , Datos de Secuencia Molecular , Proteínas del Tejido Nervioso/química , Proteínas del Tejido Nervioso/genética
16.
Methods Find Exp Clin Pharmacol ; 23(7): 395-9, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11771854

RESUMEN

To clarify the action of estrogenic endocrine disruptors on cadmium (Cd)-induced metallothionein (MT) synthesis in the liver, we investigated the effects of bisphenol A (BPA) on hepatic MT-I mRNA expression and MT contents after Cd injection. Liver damage after Cd injection was assessed by measuring glutamic-pyruvic transaminase (GPT) and glutamic-oxaloacetic transaminase (GOT) activities in the serum. It was found that BPA reduced the Cd-induced expression of MT-I mRNA and MT protein in the liver. The administration of tamoxifen, an estrogen receptor antagonist, prevented the reduction of hepatic MT content by PA. Moreover both the GPT and GOT activities of the BPA-treated groups were higher than those of the control groups. These findings suggest that BPA reduced hepatic MT synthesis after Cd injection via the estrogen receptor which resulted in increased damage to the liver.


Asunto(s)
Cloruro de Cadmio/toxicidad , Fenoles/farmacología , Receptores de Estrógenos/efectos de los fármacos , Alanina Transaminasa/sangre , Alanina Transaminasa/efectos de los fármacos , Animales , Aspartato Aminotransferasas/sangre , Aspartato Aminotransferasas/efectos de los fármacos , Compuestos de Bencidrilo , Cloruro de Cadmio/agonistas , Relación Dosis-Respuesta a Droga , Antagonistas de Estrógenos/farmacología , Etanol/administración & dosificación , Regulación de la Expresión Génica/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Masculino , Metalotioneína/biosíntesis , Metalotioneína/genética , Ratones , ARN Mensajero/metabolismo , Tamoxifeno/farmacología
17.
Brain Res ; 853(2): 310-6, 2000 Jan 24.
Artículo en Inglés | MEDLINE | ID: mdl-10640628

RESUMEN

Metallothionein (MT)-III, originally discovered as a growth inhibitory factor (GIF), is a brain specific isomer of MTs and is markedly reduced in the brain of patients with Alzheimer's disease (AD) or other neurodegenerative diseases. We analyzed the level and regulation of mRNA expression of MT-III in immortalized fetal mouse brain glial cells (VR-2g) by reverse transcriptase-polymerase chain reaction (RT-PCR). We have recently reported that dopamine (DA) increases the expression of MT-III mRNA in vitro. In this study, we investigated the mechanism of such increase by examining the effects of DA agonists (SKF38393 or bromocriptine) and DA antagonists (SCH23390 or sulpiride) on the expression of MT-III mRNA. MT-III mRNA did not change by either agonist and DA-increased MT-III mRNA was not inhibited by either antagonist. These results suggested that the induction of MT-III mRNA by DA was not mediated by stimulation of DA receptors. On the other hand, DA-induced MT-III mRNA expression was strongly inhibited by the addition of antioxidants (glutathione, vitamin E or ascorbic acid), indicating that DA-enhanced MT-III mRNA was mediated by reactive oxygen species. Our results suggest that oxidative stress may be one of the principle factors that modulate MT-III mRNA expression.


Asunto(s)
Antioxidantes/farmacología , Dopamina/farmacología , Metalotioneína/biosíntesis , Neuroglía/efectos de los fármacos , ARN Mensajero/biosíntesis , Adrenérgicos/farmacología , Agonistas alfa-Adrenérgicos/farmacología , Animales , Ácido Ascórbico/farmacología , Línea Celular , Agonistas de Dopamina/farmacología , Antagonistas de Dopamina/farmacología , Antagonistas de los Receptores de Dopamina D2 , Relación Dosis-Respuesta a Droga , Glutatión/farmacología , Glicerol-3-Fosfato Deshidrogenasa (NAD+) , Glicerolfosfato Deshidrogenasa/genética , Glicerolfosfato Deshidrogenasa/metabolismo , Levodopa/farmacología , Metalotioneína/genética , Ratones , Neuroglía/citología , Neuroglía/metabolismo , Norepinefrina/farmacología , Oxidopamina/farmacología , Isoformas de Proteínas/biosíntesis , Isoformas de Proteínas/genética , ARN Mensajero/efectos de los fármacos , Receptores de Dopamina D1/agonistas , Receptores de Dopamina D1/antagonistas & inhibidores , Receptores de Dopamina D2/agonistas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Vitamina E/farmacología
18.
Nihon Yakurigaku Zasshi ; 116(6): 385-94, 2000 Dec.
Artículo en Japonés | MEDLINE | ID: mdl-11188507

RESUMEN

According to the "Guideline for Diagnosis and Treatment of Asthma" established by the Japanese Society of Allergy in 1998, inhaled adrenergic beta 2 agonists and inhaled corticosteroids are recommended for treatment of asthma. Thereafter, the development of new drugs for the treatment of asthma has begun changing. The concepts upon which the development of investigational drugs for asthma are based include improvements of drug delivery systems (ease of use, long-acting preparations, fewer side-effects), device design and appropriate auxiliary instrumentation. Moreover, chronic asthma has come to be recognized as an inflammatory disease of airway mucosa. At present, various antiallergic compounds such as tachykinin, leucotrien, PAF antagonists and others are under investigation thanks to the identification of new chemical mediators of airway inflammation and studies have progressed to the synthesis and manufacturing of new pharmaceuticals with antagonistic action. Thus, this review classified and introduced various new investigational anti-asthma and further describes the structure-activity relationships of beta 2 agonists and inhaled corticosteroids.


Asunto(s)
Diseño de Fármacos , Agonistas Adrenérgicos beta , Antialérgicos , Antiasmáticos , Antiinflamatorios , Antagonistas Colinérgicos , Sistemas de Liberación de Medicamentos , Humanos , Estado Asmático/tratamiento farmacológico , Esteroides , Teofilina
19.
Methods Find Exp Clin Pharmacol ; 22(9): 663-6, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11294006

RESUMEN

Metallothioneins (MTs) are low molecular weight proteins that have been considered to be important metal-binding proteins in the defense against cadmium (Cd) toxicity in animals. These proteins are known to be induced by the injection of heavy metals such as Cd. Previously, we developed the RT-PCR method to measure the level of MT mRNA expression. In this study, we analyzed the time course and dose response of Cd-induced MT-I mRNA expression in the male and female mouse liver. By this method, we measured hepatic MT-I mRNA expression which reached the highest peak 6 h after subcutaneous injection of 1.1 mg/kg Cd in 9-week old male and female mice compared with those of corresponding controls (0 h). There was no statistical difference in the hepatic MT-I mRNA expression between male and female mice 6 h after the injection of this dosage. However, it is notable that the MT-I mRNA expression in male mice was much higher than that in females 6 h after injection of 0.5 mg/kg Cd. Thus, the induction of hepatic MT-I mRNA expression is dependent on the sex of the mouse, the dosage and the time course of Cd.


Asunto(s)
Cadmio/farmacología , Hígado/metabolismo , Metalotioneína/biosíntesis , ARN Mensajero/biosíntesis , Animales , Relación Dosis-Respuesta a Droga , Femenino , Hígado/efectos de los fármacos , Masculino , Ratones , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
20.
Dent Mater J ; 18(3): 271-7, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10786137

RESUMEN

The aim of this study was to assess the toxicological responses of a resin composite containing TiK2F6 and NaF in rat dental pulp cells. Trial resin composite liners were made, containing 3 wt% fluorides (TiK2F6 or NaF). These specimens were immersed in 5 ml of cell culture medium supplemented at 37 degrees C for 24 hours. The eluates were used for the experiments. We judged the cytotoxicity of the samples by the cell viability. The original elute solution was serially diluted and then the medium was exchanged for the dilute medium. The cell viability at 1, 2 or 5 days after commencement of re-culturing was calculated. The viability of cells in the eluate from the resin composite liners containing TiK2F6 and NaF decreased with time. The cytotoxicity of TiK2F6 was weaker than that of NaF at all times.


Asunto(s)
Cariostáticos/toxicidad , Resinas Compuestas/toxicidad , Pulpa Dental/efectos de los fármacos , Fluoruros/toxicidad , Compuestos de Potasio/toxicidad , Fluoruro de Sodio/toxicidad , Titanio/toxicidad , Animales , Supervivencia Celular/efectos de los fármacos , Células Clonales , Recubrimiento de la Cavidad Dental/efectos adversos , Pulpa Dental/citología , Ensayo de Materiales , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA